Ticagrelor overcomes high platelet reactivity in patients with acute myocardial infarction or coronary artery in-stent restenosis: a randomized controlled trial

High on-treatment platelet reactivity (HTPR) is accompanied by an increased risk of adverse outcomes. Direct comparison of the antiplatelet effects between ticagrelor and high-dose clopidogrel has not yet been reported in acute myocardial infarction (AMI) or coronary artery in-stent restenosis (ISR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Pan, Yang, Yawei, Chen, Tao, Liu, Yu, Cao, Ailin, Liu, Junmei, Wang, Zhuo, Zhao, Xianxian, Qin, Yongwen, Ma, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563354/
https://www.ncbi.nlm.nih.gov/pubmed/26350388
http://dx.doi.org/10.1038/srep13789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563354/
https://www.ncbi.nlm.nih.gov/pubmed/26350388
http://dx.doi.org/10.1038/srep13789

Ejemplares similares